IMDX

NASDAQStock

Insight Molecular Diagnostics Inc.

$4.91+0.02 (+0.41%)

52-Week Range

$2.40

$8.48

Key Stats

Market Cap

—

P/E Ratio

—

Dividend Yield

—

Beta

1.35

Volume

127.1K

Avg Volume

87.5K

Performance

-12.37%

-2.59%

+58.25%

YTD

-31.70%

+54.75%

Price Chart

ETF Exposure

IMDX is held by 8 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
IWC	iShares Micro-Cap ETF	0.01%	29,032	$152K	$1.27B	0.60%
VXF	Vanguard Extended Market ETF	0.00%	220,580	$1.4M	$84.10B	0.05%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	9	$86	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	349	$3K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	1	$14	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	199,139	$1.3M	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	1,047	$9K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	90	$797	$1.29B	0.17%

About IMDX ETF Exposure

Insight Molecular Diagnostics Inc. (IMDX) is held by 8 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $4.91. Investors can gain exposure to IMDX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold IMDX, sorted by portfolio weight.